Synthesis and Characterization of Novel 1‐Methyl‐3‐(4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazole Derivatives

A series of novel 1‐methyl‐3‐(4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazoles was synthesized in three steps from 5‐(1‐methyl‐1H‐indazol‐3‐yl)‐4‐phenyl‐2H‐1,2,4‐triazole‐3(4H)‐thiones. 5‐(1‐Methyl‐1H‐indazol‐3‐yl)‐4‐phenyl‐2H‐1,2,4‐triazole‐3(4H)‐thiones were converted into 1‐methyl‐3‐(5‐(methylsulfonyl)‐4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazoles upon methylation followed by treatment with aq. KMnO₄. The reaction of 1‐methyl‐3‐(5‐(methylsulfonyl)‐4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazoles with Raney nickel resulted in desulphonylation to afford corresponding 1‐methyl‐3‐(4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazoles. All the new synthesized compounds were characterized by spectral techniques.     

Triterpenoid Saponins from Schefflera arboricola

Four new triterpenoid saponins, named scheffarboside A – D ( 1 – 4 ), along with five known saponins were isolated from the stems of Schefflera arboricola. The structures of the four new saponins were determined as 3‐O‐(O‐β‐glucuronopyranosyl‐(1 → 3)‐O‐α‐rhamnopyranosyl‐(1 → 2)‐α‐arabinopyranosyl)oleanolic acid ( 1 ), 3‐O‐(O‐α‐arabinopyranosyl‐(1 → 4)‐O‐α‐arabinopyranosyl‐(1 → 3)‐O‐α‐rhamnopyranosyl‐(1 → 2)‐α‐arabinopyranosyl)oleanolic acid ( 2 ), 3‐O‐(O‐α‐arabinopyranosyl‐(1 → 4)‐O‐α‐arabinopyranosyl‐(1 → 3)‐O‐α‐rhamnopyranosyl‐(1 → 2)‐α‐arabinopyranosyl)hederagenin ( 3 ), 3‐O‐(O‐α‐arabinopyranosyl‐(1 → 4)‐O‐α‐arabinopyranosyl‐(1 → 3)‐O‐α‐rhamnopyranosyl‐(1 → 2)‐α‐arabinopyranosyl)oleanolic acid O‐α‐rhamnopyranosyl‐(1 → 4)‐O‐β‐glucopyranosyl‐(1 → 6)‐β‐glucopyranosylester ( 4 ), respectively, on the basis of spectroscopic and chemical degradation methods.     

Highly Polar Triterpenoid Saponins from the Roots of Saponaria officinalis L.

Five new triterpenoid saponins, including 3‐O‐β‐d ‐galactopyranosyl‐(1→2)‐[β‐d ‐xylopyranosyl‐(1→3)]‐β‐d ‐glucuronopyranosyl quillaic acid 28‐O‐β‐d ‐glucopyranosyl‐(1→3)‐β‐d ‐xylopyranosyl‐(1→4)‐α‐l ‐rhamnopyranosyl‐(1→2)‐[β‐d ‐xylopyranosyl‐(1→3)‐(4‐O‐acetyl)‐β‐d ‐quinovopyranosyl‐(1→4)]‐β‐d ‐fucopyranoside ( 1 ), 3‐O‐β‐d ‐galactopyranosyl‐(1→2)‐[β‐d ‐xylopyranosyl‐(1→3)]‐β‐d ‐glucuronopyranosyl quillaic acid 28‐O‐(6‐O‐acetyl)‐β‐d ‐glucopyranosyl‐(1→3)‐[β‐d ‐xylopyranosyl‐(1→4)]‐α‐l ‐rhamnopyranosyl‐(1→2)‐[β‐d ‐xylopyranosyl‐(1→3)‐(4‐O‐acetyl)‐β‐d ‐quinovopyranosyl‐(1→4)]‐β‐d ‐fucopyranoside ( 2 ), 3‐O‐β‐d ‐galactopyranosyl‐(1→2)‐[β‐d ‐xylopyranosyl‐(1→3)]‐β‐d ‐glucuronopyranosyl quillaic acid 28‐O‐β‐d ‐xylopyranosyl‐(1→4)‐α‐l ‐rhamnopyranosyl‐(1→2)‐[β‐d ‐xylopyranosyl‐(1→3)‐(4‐O‐acetyl)‐β‐d ‐quinovopyranosyl‐(1→4)]‐β‐d ‐fucopyranoside ( 3 ), 3‐O‐β‐d ‐galactopyranosyl‐(1→2)‐[β‐d ‐xylopyranosyl‐(1→3)]‐β‐d ‐glucuronopyranosyl quillaic acid 28‐O‐β‐d ‐glucopyranosyl‐(1→3)‐β‐d ‐xylopyranosyl‐(1→4)‐α‐l ‐rhamnopyranosyl‐(1→2)‐[(4‐O‐acetyl)‐β‐d ‐quinovopyranosyl‐(1→4)]‐β‐d ‐fucopyranoside ( 4 ), 3‐O‐β‐d ‐galactopyranosyl‐(1→2)‐[β‐d ‐xylopyranosyl‐(1→3)]‐β‐d ‐glucuronopyranosyl quillaic acid 28‐O‐(6‐O‐acetyl)‐β‐d ‐glucopyranosyl‐(1→3)‐[β‐d ‐xylopyranosyl‐(1→4)]‐α‐l ‐rhamnopyranosyl‐(1→2)‐[(4‐O‐acetyl)‐β‐d ‐quinovopyranosyl‐(1→4)]‐β‐d ‐fucopyranoside ( 5 ) together with two known congeners, saponariosides A ( 6 ) and B ( 7 ) were isolated from the roots of Saponaria officinalis L. Their structures were elucidated by extensive spectroscopic methods, including 1D‐ (¹H, ¹³C) and 2D‐NMR (DQF‐COSY, TOCSY, HSQC, and HMBC) experiments, HR‐ESI‐MS, and acid hydrolysis.     

Triterpenoid Saponins from Vaccaria segetalis

Four novel triterpenoid saponins, Vaccariside B‐E (1–4), were isolated from the seeds of Vaccaria segetalis and their structures were elucidated as 3‐O‐β‐D‐galactopyranosyl‐(1–2)‐β‐D‐glucuronopyranosyl quillaic add 28‐O‐β‐D‐xylopyranosyl‐(1–3)‐α‐L rhamno‐pyranosyl‐(1–2)‐[α‐L‐arabinofura‐nosyl‐(1–3)]‐4‐O‐acetyl‐β‐D)‐fucopyranoside (1), 3‐O‐β‐D‐galactopyranosyl ‐ (1–2) ?3‐O‐acetyl‐β‐D ‐ glucuronopyranosyl quillaic acid 28‐O‐β‐D‐xylopyranosyl‐(1–3)‐α‐L‐rhamnopyra‐nosyl‐(1–2)‐[α‐L‐arabinofuranosyl‐(1–3)]‐4‐O‐acetyl‐β‐D‐fucopyranoside (2), 3‐O‐β‐D‐galactopyranosyl‐(1–2)‐β‐D‐glucuronopyranosyl quillaic add 28‐O‐α‐L‐arabinopyranosyl‐(1–3)‐α‐L‐rhamnopyranosyl‐(1–2)‐[α‐L‐arabinofuranosyl‐(1–3)]‐4‐O‐acetyl‐β‐D‐fucopyranoside (3), 3‐O‐β‐D‐galacto‐pyranosyl‐(1–2)‐[β‐D‐xytopyranosyl‐(1–3)]‐β‐D‐glucurono‐pyranosyl quillaic add 28‐O‐β‐D‐xylopyranosyl‐(1–3)‐α‐L‐rhamnopyranosyl‐(1–2)‐[α‐L‐arabinofuranosyl‐(1–3)]‐4‐O‐acetyl‐β‐D‐fucopyranoside (4), respectively.     

Synthesis of β-（ 1→6）-Branched （ 1→3）-Glucononaoside with Alter-nate β- and α-Bonds in the Backbone

Lauryl glycoside of β-D-Glcp-(1→3)-[β-D-Glcp-(1→6)-]α-D-Glcp-(1→3)-β-D-Glcp-(1→3)-[β-D-Glcp-(1→6)-]α-D-Glcp-(1→3)-β-D-Glcp-(1→3)-[β-D-Glcp-(1→6)-]β-D-Glcp was synthesized through 3 3 3 strategy. 3-O-Allyl-2,4,6-tri-O-benzoyl-β-D-glucopyranosyl-(1→3)- -[2, 3, 4, 6-tetra-O-benzoyl-β-D-glucopyranosyl-(1→6)-] 1,2-O-isopropylidene-α-D-glucofuranose was used as the key intermediate which was converted to the corresponding trisaccharide donor and acceptor readily.     

Synthesis of novel 5H‐Pyrimido[5,4‐b]mdole‐(1H,3H)2,4‐diones as potential ligands for the cloned α1‐adrenoceptor subtypes

A new series of 3‐[ω‐[4‐(4‐substituted phenyl)piperazin‐1‐yl]alkyl]‐5H‐pyrimido[5,4‐b]indole‐(1H,3H)‐2,4‐diones ( 3–10 and 12–13 ) were synthesized from the N‐(2‐chloroethyl)‐N'‐[3‐(2‐ethoxycarbonyl)indolyl] urea ( 1 ) or the N‐(3‐chloropropyl)‐N'‐[3‐(2‐ethoxycarbonyl)indolyl] urea ( 2 ) and a number of 1‐(4‐substi‐tuted‐phenyl)piperazines. 3‐[2‐[4‐(4‐Aminophenyl)piperazin‐1‐yl]ethyl]‐5H‐pyrimido[5,4‐b]indole‐(1H,3H)2,4‐dione ( 14 ) was obtained by reduction of the parent nitro compound 8 . The obtained 5H‐pyrimido[5,4‐b]indole‐(1H,3H)2,4‐dione derivatives were tested towards cloned α_1A, α_1B and α_1D adrenergic receptors subtypes in binding assays. Some compounds showed good affinity and selectivity for the α_1D‐adrenoceptor subtype.     

Synthesis and Fungicidal Activity of 5‐Aryl‐1‐(aryloxyacetyl)‐3‐(tert‐butyl or phenyl)‐4‐(1H‐1,2,4‐triazol‐1‐yl)‐4,5‐dihydropyrazole

A series of novel 5‐aryl‐1‐(aryloxyacetyl)‐3‐(tert‐butyl or phenyl)‐4‐(1H‐1,2,4‐triazol‐1‐yl)‐4,5‐dihydropyrazole 3a – 3n were synthesized by the annulation of 2‐aryloxyacetohydrazides with 3‐aryl‐1‐t‐butyl (or phenyl)‐2‐(1H‐1,2,4‐triazol‐1‐yl)prop‐2‐en‐1‐ones ( 2 ) in the presence of a catalytic amount of acetic acid. Compounds 2 were obtained by the Knoevenagel reactions of 1‐t‐butyl (or phenyl)‐2‐(1H‐1,2,4‐triazol‐1‐yl)ethanone ( 1 ) with aromatic aldehydes in the presence of piperidine. Their structures were confirmed by IR, ¹H‐NMR, ESI‐MS, and elemental analyses. The preliminary bioassay indicated that some compounds displayed moderate to excellent fungicidal activity. For example, compounds 3l , 3m , and 3n possessed 100% inhibition against Cercospora arachidicola Hori at the concentration of 50 mg/L.     

Three New Phthalides from Gnaphalium adnatum

Three new phthalides, gnaphalides A–C ( 1 – 3 , resp.), together with three known phthalides, were isolated from the aerial part of Gnaphalium adnatum. The structures of the new compounds were elucidated as 6‐(1,1‐dimethylprop‐2‐en‐1‐yl)‐5,7‐dihydroxy‐2‐benzofuran‐1(3H)‐one ( 1 ), 5‐hydroxy‐7‐[(2‐hydroxy‐3‐methylbut‐3‐en‐1‐yl)oxy]‐2‐benzofuran‐1(3H)‐one ( 2 ), and 1,3‐dihydro‐7‐[(3‐methylbut‐2‐en‐1‐yl)oxy]‐1‐oxo‐2‐benzofuran‐5‐yl β‐D ‐glucopyranoside ( 3 ) on the basis of spectral analyses. The structure of 1 was also confirmed by X‐ray crystallographic analysis. The three known phthalides, identified as 5,7‐dihydroxyisobenzofuran‐1(3H)‐one ( 4 ), anaphatol ( 5 ), and 7‐O‐(β‐glucopyranosyl)‐5‐hydroxyisobenzofuran‐1(3H)‐one ( 6 ), were isolated from the genus Gnaphalium for the first time.     

Synthesis of Certain New Thiazole and 1,3,4‐Thiadiazole Derivatives via the Utility of 3‐Acetylindole

2‐(2‐(1‐(1H‐Indol‐3‐yl)ethylidene)‐hydrazinyl)‐4‐substituted 5‐(aryldiazenyl)thiazoles and 5‐((1‐(1H‐indol‐3‐yl)ethylidene)hydrazono)‐2‐substituted‐4‐phenyl‐4,5‐dihydro‐1,3,4‐thiadiazoles were synthesized via reaction of hydrazonoyl halides and 2‐(1‐(1H‐indol‐3‐yl)ethylidene)hydrazine‐1‐carbothioamide and alkyl 2‐(1‐(1H‐indol‐3‐yl)ethylidene)hydrazine‐1‐carbodithioate in ethanolic triethylamine. Structures of the newly synthesis were elucidated on the basis of elemental analysis, spectral data, and alternative synthetic route whenever possible.     

Synthese und Struktur hochfunktionalisierter 2, 3‐Dihydro‐1H‐1, 3, 2‐diazaborole

Synthesis and Structure of Highly Functionalized 2, 3‐Dihydro‐1H‐1, 3, 2‐diazaboroles A series of differently substituted 2, 3‐dihydro‐1H‐1, 3, 2‐diazaboroles has been prepared by various methods. 1, 3‐Di‐tert‐butyl‐2‐trimethylsilylmethyl‐1H‐1, 3, 2‐diazaborole ( 7 ), 2‐isobutyl‐1, 3‐bis(1‐cyclohexylethyl)‐1H‐1, 3, 2‐diazaborole ( 8 ), 1, 3‐bis‐(1‐cyclohexylethyl)‐2‐trimethylsilylmethyl‐1H‐1, 3, 2‐diazaborole ( 9 ) 1, 3‐bis(1‐methyl‐1‐phenyl‐propyl)‐2‐trimethylsilylmethyl‐1H‐1, 3, 2diazaborole ( 10 ) and 2‐bromo‐1, 3‐bis(1‐methyl‐1‐phenyl‐propyl)‐1H‐1, 3, 2‐diazaborole ( 11 ) were formed by reaction of the corresponding 1, 4‐diazabutadienes with the boranes Me₃SiCH₂BBr₂, iBuBBr₂ and BBr₃ followed by reduction of the resulting borolium salts [R¹ = tBu, Me(cHex)CH, [Me(Et)Ph]C; R² = Me₃SiCH₂, iBu, Br] with sodium amalgam. Treatment of 11 and 12 with silver cyanide afforded the 2‐cyano‐1, 3, 2‐diazaboroles 13 and 14 . An alternative route to compound 8 is based on the alkylation of 2‐bromo‐1, 3, 2‐diazaborole 12 with isobutyllithium. Equimolar amounts of 13 and isobutyllithium give rise to the formation of 15 . The new compounds were characterized by ¹H‐, ¹³C‐, ¹¹B‐NMR, IR and mass spectra. The molecular structures of 7 and meso ‐10 were confirmed by x‐ray structural analysis.     

Further Prenylated Bi‐ and Tricyclic Phloroglucinol Derivatives from Hypericum papuanum

From the petroleum‐ether extract of the dried aerial parts of Hypericum papuanum, three new prenylated tricyclic and four new bicyclic acylphloroglucinol derivatives were isolated by bioactivity‐guided fractionation. The structures of the bicyclic compounds enaimeone A, B, and C ( 1 / 1a , 2 / 2a , and 3 / 3a , resp.) were elucidated as rel‐(1R,5R,6S)‐4‐hydroxy‐6‐(1‐hydroxy‐1‐methylethyl)‐5‐methyl‐1‐(3‐methylbut‐2‐enyl)‐3‐(2‐methylpropanoyl)‐bicyclo[3.2.1]oct‐3‐ene‐2,8‐dione ( 1 / 1a ), rel‐(1R,5R,6R)‐4‐hydroxy‐6‐(1‐hydroxy‐1‐methylethyl)‐5‐methyl‐1‐(3‐methylbut‐2‐enyl)‐3‐(2‐methylpropanoyl)bicyclo[3.2.1]oct‐3‐ene‐2,8‐dione ( 2 / 2a ), rel‐(1R,5R,6R)‐4‐hydroxy‐6‐(1‐hydroxy‐1‐methylethyl)‐5‐methyl‐3‐(2‐methylbutanoyl)‐1‐(3‐methylbut‐2‐enyl)bicyclo[3.2.1]oct‐3‐ene‐2,8‐dione ( 3 / 3a ). The tricyclic isolates 8‐hydroxy‐3β‐(1‐hydroxy‐1‐methylethyl)‐4,4,7‐trimethyl‐9‐(2‐methylpropanoyl)‐5βH‐tricyclo[5.3.1.0^1,5]undec‐8‐ene‐10,11‐dione ( 4 ), 8‐hydroxy‐3α‐(1‐hydroxy‐1‐methylethyl)‐4,4,7‐trimethyl‐9‐(2‐methylpropanoyl)‐5βH‐tricyclo[5.3.1.0^1,5]undec‐8‐ene‐10,11‐dione ( 5 ), and 8‐hydroxy‐3α‐(1‐hydroxy‐1‐methylethyl)‐4,4,7‐trimethyl‐9‐(2‐methylbutanoyl)‐5βH‐tricyclo[5.3.1.0^1,5]undec‐8‐ene‐10,11‐dione ( 6 ), and their corresponding tautomers 4a , 5a , and 6a , were named 1′‐hydroxyialibinones A, B, and D, respectively. Oxidative decomposition of furonewguinone A (=2,3,3a,5‐tetrahydro‐3a‐hydroxy‐2‐(1‐hydroxy‐1‐methylethyl)‐5‐methyl‐5‐(3‐methylbut‐2‐enyl)‐7‐(2‐methylpropanoyl)‐benzofuran‐4,6‐dione; 7 ) led to furonewguinone B (=3,3a,7,7a‐tetrahydro‐3a,6,7a‐trihydroxy‐2‐(1‐hydroxy‐1‐methylethyl)‐7‐methyl‐7‐(3‐methylbut‐2‐enyl)‐5‐(2‐methylpropanoyl)benzofuran‐4(2H)‐one; 8 / 8a ). Structure elucidation was based on extensive 1D and 2D NMR studies, as well as on data derived from mass spectrometry. Furthermore, the cytotoxicity towards KB nasopharyngeal carcinoma cells and the antibacterial activity were determined.     

Three New Neolignans from the Aril of Myristica fragrans

Three new neolignans, named 1‐deoxycarinatone ( 1 ), isodihydrocarinatidin ( 2 ), and isolicarin A ( 3 ), together with the known neolignan (+)‐dehydrodiisoeugenol ( 4 ), were isolated from mace (the aril of Myristica fragrans Houtt .). Their structures were elucidated as 2‐[(1S)‐2‐(4‐hydroxy‐3‐methoxyphenyl)‐1‐methylethyl]‐6‐methoxy‐4‐(prop‐2‐enyl)phenol ( 1 ), 4‐[(2R,3R)‐2,3‐dihydro‐7‐methoxy‐3‐methyl‐5‐(prop‐2‐enyl)benzofuran‐2‐yl]‐2‐methoxyphenol ( 2 ), and 4‐{(2S,3R)‐2,3‐dihydro‐7‐methoxy‐3‐methyl‐5‐[(1E)‐prop‐1‐enyl]benzofuran‐2‐yl}‐2‐methoxyphenol ( 3 ) on the basis of spectroscopic data.     

A Simple and Efficient Process for the Synthesis of Novel Heterocycles Containing Benzofuran Moiety Using Thiocarbohydrazide as a Precursor

A simple and efficient process for the synthesis of novel heterocycles starting from thiocarbohydrazide was reported. Reaction of 2‐acetylbenzofuran ( 1 ) and thiocarbohydrazide ( 2 ) in ethanol containing acetic acid produced the corresponding thiocarbohydrazone 3 in 86% yield. Reaction of 3 and isatin ( 4 ) gave N,2‐bis(2‐oxoindolin‐3‐ylidene)hydrazine‐1‐carbothiohydrazine ( 6 ) in 65% yield, rather than the expected product, 3‐[(1‐methyl‐1‐benzofur‐2‐ylmethylidene)amino]‐1‐{[(3Z)‐2‐oxo‐2,3‐dihydro‐1H‐indol‐3‐ylidene]amino}thiourea ( 5 ). Reaction of 2‐((3‐(benzofuran‐2‐yl)‐1‐phenyl‐1H‐pyrazol‐4‐yl)methylene)hydrazine carbothioamide ( 9 ) and chloroacetic acid or hydrazonoyl chloride 11 in basic medium gave (Z)‐2‐((E)‐((3‐(benzofuran‐2‐yl)‐1‐phenyl‐1H‐pyrazol‐4‐yl)methylene)hydrazono)thiazolidin‐4‐one ( 10 ) or 2‐((E)‐2‐((3‐(benzofuran‐2‐yl)‐1‐ phenyl‐1H‐pyrazol‐4‐yl)methylene)hydrazinyl)‐4‐((E)‐(4‐fluorophenyl)diazenyl)‐5‐methylthiazole ( 12 ) in 62% or 74%, respectively.     

First Synthesis and Characterization of Stereoisomers of Choleretic Drug Dihydroxydibutylether

Dihydroxydibutylether (DHBE) is a choleretic drug used for the treatment of gallstone and hepatic disorders due to its choleretic activity and hepatoprotective action. The drug is a mixture of three regioisomers. The main regioisomer 3‐(3‐hydroxylbutoxy)‐1‐butanol ( III ) contains four stereoisomers, including (R)‐3‐((R)‐3‐hydroxylbutoxy)‐1‐butanol ( IIIa ), (R)‐3‐((S)‐3‐hydroxylbutoxy)‐1‐butanol ( IIIb ), (S)‐3‐((R)‐3‐hydroxylbutoxy)‐1‐butanol ( IIIc ) and (S)‐3‐((S)‐3‐hydroxylbutoxy)‐1‐butanol ( IIId ). In this paper, the four stereoisomers are synthesized separately for the first time.     

Novel Polyoxygenated Spirostanol Glycosides from the Rhizomes of Helleborus orientalis

The two new polyoxygenated spirostanol bisdesmosides 1 and 2 and the new trisdesmoside 3 , named hellebosaponin A ( 1 ), B ( 2 ), and C ( 3 ), respectively, were isolated from the MeOH extract of the rhizomes of Helleborus orientalis. The structures of the new compounds were elucidated as (1β,3β,23S,24S)‐21‐(acetyloxy)‐24‐[(β‐D ‐fucopyranosyl)oxy]‐3,23‐dihydroxyspirosta‐5,25(27)‐dien‐1‐yl O‐β‐D ‐apiofuranosyl‐(1→3)‐O‐(4‐O‐acetyl‐α‐L ‐rhamnopyranosyl)‐(1→2)‐O‐[β‐D ‐xylopyranosyl‐(1→3)]‐α‐L ‐arabinopyranoside ( 1 ), (1β,3β,23S,24S)‐ 21‐(acetyloxy)‐24‐{[O‐β‐D ‐glucopyranosyl‐(1→4)‐β‐D ‐fucopyranosyl]oxy}‐3,23‐dihydroxyspirosta‐5,25(27)‐dien‐1‐yl O‐β‐D ‐apiofuranosyl‐(1→3)‐O‐(4‐O‐acetyl‐α‐L ‐rhamnopyranosyl)‐(1→2)‐O‐[β‐D ‐xylopyranosyl‐(1→3)]‐ α‐L ‐arabinopyranoside ( 2 ), and (1β,3β,23S,24S)‐24‐[(β‐D ‐fucopyranosyl)oxy]‐21‐{[O‐β‐D ‐glucopyranosyl‐(1→2)‐β‐D ‐galactopyranosyl]oxy}‐3,23‐dihydroxyspirosta‐5,25(27)‐dien‐1‐yl O‐β‐D ‐apiofuranosyl‐(1→3)‐O‐(4‐O‐acetyl‐α‐L ‐rhamnopyranosyl)‐(1→2)‐O‐[β‐D ‐xylopyranosyl‐(1→3)]‐α‐L ‐arabinopyranoside ( 3 ), respectively, on the basis of detailed spectroscopic studies and chemical evidence.     

Novel Benzyl‐ or 4‐Cyanobenzyl‐Substituted N‐Heterocyclic (Bromo)(carbene)silver(I) and (Carbene)(chloro)gold(I) Complexes: Synthesis and Preliminary Cytotoxicity Studies

N‐Heterocyclic carbene (NHC) complexes bromo(1,3‐dibenzyl‐1,3‐dihydro‐2H‐imidazol‐2‐ylidene)silver(I) ( 2a ), bromo[1‐(4‐cyanobenzyl)‐3‐methyl‐1,3‐dihydro‐2H‐imidazol‐2‐ylidene]silver(I) ( 2b ), and bromo[1‐(4‐cyanobenzyl)‐3‐methyl‐1,3‐dihydro‐2H‐benzimidazol‐2‐ylidene]silver(I) ( 2c ) were prepared by the reaction of 1,3‐dibenzyl‐1H‐imidazol‐3‐ium bromide ( 1a ), 3‐(4‐cyanobenzyl)‐1‐methyl‐1H‐imidazol‐3‐ium bromide ( 1b ), and 3‐(4‐cyanobenzyl)‐1‐methyl‐1H‐benzimidazol‐3‐ium bromide ( 1c ), respectively, with silver(I) oxide. NHC Complexes chloro(1,3‐dibenzyl‐1,3‐dihydro‐2H‐imidazol‐2‐ylidene)gold(I) ( 3a ), chloro[1‐(4‐cyanobenzyl)‐3‐methyl‐1,3‐dihydro‐2H‐imidazol‐2‐ylidene]gold(I) ( 3b ), and chloro[1‐(4‐cyanobenzyl)‐3‐methyl‐1,3‐dihydro‐2H‐benzimidazol‐2‐ylidene]gold(I) ( 3c ) were prepared via transmetallation of corresponding (bromo)(NHC)silver(I) complexes with chloro(dimethylsulfido)gold(I). The complex 3a was characterized in two polymorphic forms by single‐crystal X‐ray diffraction showing two rotamers in the solid state. The cytotoxicities of all three bromo(NHC)silver(I) complexes and three (chloro)(NHC)gold(I) complexes were investigated through 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐2H‐tetrazolium bormide (MTT)‐based preliminary in vitro testing on the Caki‐1 cell line in order to determine their IC₅₀ values. (Bromo)(NHC)silver(I) complexes 2a – 2c and (chloro)(NHC)gold(I) complexes 3a – 3c were found to have IC₅₀ values of 27±2, 28±2, 34±6, 10±1, 12±5, and 12±3 μM , respectively, on the Caki‐1 cell line.     

Furostane‐Type Steroidal Saponins from the Roots of Chlorophytum borivilianum

Four new furostanol steroid saponins, borivilianosides A–D ( 1 – 4 , resp.), corresponding to (3β,5α,22R,25R)‐26‐(β‐D ‐glucopyranosyloxy)‐22‐hydroxyfurostan‐3‐yl O‐β‐D ‐xylopyranosyl‐(1→3)‐O‐β‐D ‐glucopyranosyl‐(1→4)‐O‐[α‐L ‐rhamnopyranosyl‐(1→2)]‐β‐D ‐galactopyranoside ( 1 ), (3β,5α,22R,25R)‐ 26‐(β‐D ‐glucopyranosyloxy)‐22‐methoxyfurostan‐3‐yl O‐β‐D ‐xylopyranosyl‐(1→3)‐O‐β‐D ‐glucopyranosyl‐(1→4)‐O‐[α‐L ‐rhamnopyranosyl‐(1→2)]‐β‐D ‐galactopyranoside ( 2 ), (3β,5α,22R,25R)‐26‐(β‐D ‐glucopyranosyloxy)‐22‐methoxyfurostan‐3‐yl O‐β‐D ‐xylopyranosyl‐(1→3)‐O‐[β‐D ‐glucopyranosyl‐(1→2)]‐O‐β‐D ‐glucopyranosyl‐(1→4)‐β‐D ‐galactopyranoside ( 3 ), and (3β,5α,25R)‐26‐(β‐D ‐glucopyranosyloxy)furost‐20(22)‐en‐3‐yl O‐β‐D ‐xylopyranosyl‐(1→3)‐O‐[β‐D ‐glucopyranosyl‐(1→2)]‐O‐β‐D ‐glucopyranosyl‐(1→4)‐β‐D ‐galactopyranoside ( 4 ), together with the known tribuluside A and (3β,5α,22R,25R)‐26‐(β‐D ‐glucopyranosyloxy)‐22‐methoxyfurostan‐3‐yl O‐β‐D ‐xylopyranosyl‐(1→2)‐O‐[β‐D ‐xylopyranosyl‐(1→3)]‐O‐β‐D ‐glucopyranosyl‐(1→4)‐O‐[α‐L ‐rhamnopyranosyl‐(1→2)]‐β‐D ‐galactopyranoside were isolated from the dried roots of Chlorophytum borivilianum Sant and Fern . Their structures were elucidated by 2D ‐NMR analyses (COSY, TOCSY, NOESY, HSQC, and HMBC) and mass spectrometry.     

New Minor Spirostane Glycosides from Ypsilandra thibetica

A further phytochemical investigation on the whole plants of Ypsilandra thibetica yielded three new spirostane glycosides, named ypsilandrosides M–O ( 1 – 3 ). Their structures were established as (3β,11α,25R)‐3,11‐dihydroxyspirost‐5‐en‐12‐one 3‐{O‐α‐L ‐rhanmopyranosyl‐(1→4)‐O‐L ‐rhanmopyranosyl‐(1→4)‐O‐[α‐L ‐rhanmopyranosyl‐(1→2)]‐β‐D ‐glucopyranoside} ( 1 ), (3β,7β,25R)‐spirost‐5‐ene‐3,7‐diol 3‐{O‐α‐L ‐rhanmopyranosyl‐(1→4)‐O‐α‐L ‐rhanmopyranosyl‐(1→4)‐O‐[α‐L ‐rhanmopyranosyl‐(1→2)]‐β‐D ‐glucopyranoside} ( 2 ), and (3β,7α,25R)‐spirost‐5‐ene‐3,7,17‐triol 3‐{O‐α‐L ‐rhanmopyranosyl‐(1→4)‐O‐α‐L ‐rhanmopyranosyl‐(1→4)‐O‐[α‐L ‐rhanmopyranosyl‐(1→2)]‐β‐D ‐glucopyranoside} ( 3 ) by means of a combination of MS, 1D‐ and 2D‐NMR spectroscopic methods, and chemical degradation. Among them, compound 3 is the first pennogenin (=(3β,25R)‐spirost‐5‐ene‐3,17‐diol) saponin whose aglycone contains an OH group at C(7). Compounds 1 – 3 were evaluated for the inhibition of the growth of five tumor cell lines, but all of them proved to be inactive.     

具有β-(1→6)-半乳吡喃糖骨架和α-L-(1→3)-阿拉伯呋喃糖侧链的阿拉伯半乳寡糖的简易合成

4-Methoxyphenyl glycoside of β-D-Galp-(1→6)-[α-L-Araf-(1→3)-]β-D-Galp-(1→6)-β-D-Galp-(1→6)-{β-D-Galp-(1→6)-[α-L-Araf-(1→3)-]β-D-Galp-(1→6)-β-D-Galp-(1→6)-}2β-D-Galp-(1→6)-[α-L-Araf-(1→)3)-]β-D-Galp-(1→)6)-β-D-Galp was synthesized with 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl trichloroacetimidate (1), 6-O-acetyl-2,3,4-tri-O-benzoyl-α-D-galactopyranosyl trichloroacetimidate (11), 4-methoxyphenyl 3-O-allyl-2,4-tri-O-benzoyl-β-D-galactopyranoside (2),isopropyl 3-O-allyl-2,4-tri-O-benzoyl--thio-β-D-galactopyranoside (12),4-methoxyphenyl 2,3,4-tri-O-benzoyl-β-D-galactopyranoside (5), and 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl trichloroacetimidate (8) as the key synthons.     

Synthesis and Reactions of Halo-,Arylazo-substituted 3-(3-(1-naphthyl)acryloyl)tropolones.Formation of(Naphthalen-1-yl)vinyl)substituted Heterocycle-fused Troponoid Compounds

The starting substrate 3‐(3‐(1‐naphthyl)acryloyl)tropolone ( 3 ) was achieved by the aldol condensation reaction of 3‐acetyltropolone with 1‐naphthaldehyde. Compound 3 reacted with bromine to afford 7‐bromo‐3‐ (3‐(1‐naphthyl)acryloyl)tropolone ( 4 ), 5,7‐dibromo‐3‐(3‐(1‐naphthyl)acryloyl)tropolone (5) according to the molar ratio of the reactants. Iodination of 3 gave 7‐iodo‐3‐(3‐(1‐naphthyl)acryloyl)tropolone ( 6 ). Azo‐coupling reactions of 3 gave the 5‐arylazo‐3‐(3‐(1‐naphthyl)acryloyl)tropolones ( 7 – 8 ). Compounds 3 , 4 , 6 reacted respectively with hydroxyamine to give the corresponding 3‐[2‐(1‐naphthyl)vinyl]‐8H‐cyclohepta[d]isoxazol‐8‐ones ( 9 – 11 ). The reactions of 3 , 5 with phenylhydrazine and substituted phenylhydrazines gave 3‐[2‐(1‐naphthyl)vinyl]‐1‐phenylcyclohepta[c]pyrazol‐8(1H)‐ones ( 12 – 18 ).